Articles from Glancy Prongay & Murray LLP

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSE: CUBI) securities between March 1, 2024 and August 8, 2024, inclusive (the “Class Period”). Customers Bancorp investors have until January 31, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQ: AEHR) securities between January 9, 2024 and March 24, 2024, inclusive (the “Class Period”). Aehr investors have until February 3, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Veradigm Inc. (OTCMKTS: MDRX) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 27, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 3, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Customers Bancorp, Inc. (“Customers Bancorp” or the “Company”) (NYSE: CUBI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of The Beauty Health Company (NASDAQ: SKIN) f/k/a Vesper Healthcare Acquisition Corp. concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of NuScale Power Corporation (NYSE: SMR) f/k/a Spring Valley Acquisition Corp. concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Aehr Test Systems, Inc. (“Aehr” or the “Company”) (NASDAQ: AEHR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of New York, captioned Corredor v. ASP Isotopes Inc., et al., Case No. 24-cv-09253, on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (“ASP Isotopes” or the “Company”) (NASDAQ: ASPI) securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”). Plaintiff pursues claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NASDAQ: AZN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) securities between February 8, 2024, and November 26, 2024, inclusive (the “Class Period”). Symbotic investors have until February 3, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 24, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Match Group, Inc. (“Match Group” or the “Company”) (NASDAQ: MTCH) securities between May 2, 2023 and November 6, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) American Depositary Shares (“ADSs”) between December 1, 2023 and September 10, 2024, inclusive (the “Class Period”). Rentokil investors have until January 27, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQ: SYM) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ASP Isotopes Inc. (“ASPI” or the “Company”) (NASDAQ: ASPI) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Rentokil Initial plc (“Rentokil” or the “Company”) (NYSE: RTO) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQ: CELH) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Match Group, Inc. (“Match Group” or the “Company”) (NASDAQ: MTCH) securities between May 2, 2023 and November 6, 2024, inclusive (the “Class Period”). Match Group investors have until January 24, 2025 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 17, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Wolfspeed, Inc. (“Wolfspeed” or the “Company”) (NYSE: WOLF) securities between August 16, 2023 and November 6, 2024, inclusive (the “Class Period”).

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Franklin Resources, Inc. (“Franklin” or the “Company”) (NYSE: BEN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of ICON Public Limited Company (“Icon” or the “Company”) (NASDAQ: ICLR) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) investors concerning the Company’s possible violations of the federal securities laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Macy’s, Inc. (“Macy’s” or the “Company”) (NYSE: M) investors concerning the Company’s possible violations of the federal securities laws.